Community Update: Novartis development of Votoplam in HD: INVEST-HD Phase 3 trial information now available katie82882 hours ago0 min read
Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease
‘Ready to fight the fight’: Huntington’s disease community delivers petitions to FDA seeking approval of uniQure gene therapy - By Gene Veritas